New York-headquartered SELLAS Life Sciences (SLS) listed on the Nasdaq in August 2017 via a merger with struggling biotech Galena Biopharma - a press release at the time stated: SELLAS’ lead asset, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results